DECAMP 1 PLUS Proposal: Prediction of Lung Cancer Using Noninvasive Biomarkers

Recruiting
18 years - 99 years
All
66 participants needed
1 Location

Brief description of study

The DECAMP 1 PLUS study will expand on previous early detection studies (DECAMP 1 and 2) to improve the efficiency of the diagnostic evaluation of patients with indeterminate pulmonary nodules. This study will investigate molecular, clinical and imaging features that may distinguish benign versus malignant disease among smokers with indeterminate pulmonary nodules in both a screening (Arm 1) and an incidental (Arm 2) clinical setting.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Lung Cancer, indeterminate pulmonary nodules
  • Age: 18 years - 99 years
  • Gender: All
Updated on 04 Aug 2024. Study ID: 843762

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center